“…If the literature on nagalase is relatively new and limited to a small, albeit significant, number of peerreviewed papers, the literature on CRP, an acute-phase protein that increases in the presence of infectious and inflammatory processes, is older and ampler and refers to a large number of conditions ranging from cancer (Allin and Nordestgaard, 2011) to autism (Brown et al, 2014), depression (McFarland et al, 2019, cardiovascular diseases (Cozlea et al, 2013), multiple sclerosis (Dowling and Cook, 1976) and anemia (Breiterman-White, 2006) to name a few. In a study on incurable cancer patients published in 2012, we demonstrated that CRP, integrated into the context of the Prognostic Inflammatory Nutritional Index (PINI) score, was a powerful marker for predicting overall survival (Fabris et al, 2012). Similar to nagalase, CRP may bear more pathogenic significance than simply being a marker; according to a recent paper "CRP is pathogenic in a number of diseases including hypertensive cardiovascular and kidney complications, diabetic nephropathy and acute and chronic kidney diseases" (Tang et al, 2017).…”